Articles

Podcasts

Videos

Out-of-pocket costs for noninsulin medications were 84.4% to 95.2% lower in Medicaid than in Marketplace plans, while out-of-pocket costs for insulin were 76.7% to 94.7% lower. 

Lower Drug Costs, Higher Utilization Observed in Diabetes Patients Enrolled in Medicaid  

The estimated prevalence of diabetes increased from 10.9% in 2013 to 12.4%  in 2018, without a significant improvement seen in adequate treatment. 

Significant Increase in Diabetes Prevalence Observed in China  

Data show Asian, Black, and Hispanic patients and those with lower income were less likely to receive treatment with GLP-1 RAs. 

Low Use of GLP-1 RAs Observed in Treatment of Type 2 Diabetes 

Dr. Shapiro discusses the implantable VC-02 device success in producing C-peptide in patients with type 1 diabetes and what is coming next. 


James Shapiro, MD: Insulin Production In T1D Patients After Stem Cell Therapy 

A high-potential drug for type 1 diabetes may not have received regulation this year, but it sparked vital conversation among experts.

Teplizumab Shows the Future Promise, Current Limitations of Diabetes Care

Dr. Jellinger discusses the lipid section of the DCRM guidelines, the role of combination therapies in lowering LDL and what is coming next for the field of diabetes in 2022. 


Paul S. Jellinger, MD: A Multidisciplinary Approach to Diabetes Care 

Fish oil intervention and DASH diet show no statistically significant effect on
glycemic control and adiposity. 

Fish Oil, DASH Diet Partially Alters Lipid Metabolism in Patients with Type 2 Diabetes

Dr. Zeitler highlights the long-term microvascular risk complications observed in T2D patients in the TODAY2 observational study. 

Phil Zeitler, MD: Risk Factor Development in Youth-Onset Type 2 Diabetes

Patients with type 2 diabetes treated with triple therapy had less hepatic steatosis and fibrosis and significantly improved insulin sensitivity versus conventional therapy. 

Triple Therapy In T2D Care Linked To Lower Rate Of Hepatic Steatosis, Fibrosis 

Data show the age-adjusted prevalence of hyperinsulinemia in adults without diabetes increased by 18% in the study population between 1999 - 2000 and 2017 - 2018. 

Hyperinsulinemia Rates in US Adults Significantly Increased Over 20 Year Period   

Diabetes

Diabetes condition center page is a comprehensive resource for clinical news and insights on diabetic and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for type 1 and type 2 diabetes, as well as related endocrinological conditions and illnesses. 

Exocrine Pancreatic Insufficiency

On the HCPLive exocrine pancreatic insufficiency page, resources on the topics of medical news and expert insight into EPI can be found. Content includes articles, interviews, videos, podcasts, and breaking news on the disease, and more.

Low-T

The HCPLive low-T page is a comprehensive resource for clinical news and insights on low testosterone. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for low-T, and more.

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Endocrinology